- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neutralizing antibody titres in SARS-CoV-2 infections ; volume:12 ; number:1 ; day:4 ; month:1 ; year:2021 ; pages:1-7 ; date:12.2021
Nature Communications ; 12, Heft 1 (4.1.2021), 1-7, 12.2021
- Urheber
-
Lau, Eric H. Y.
Tsang, Owen T. Y.
Hui, David S. C.
Kwan, Mike Y. W.
Chan, Wai-hung
Chiu, Susan S.
Ko, Ronald L. W.
Chan, Kin H.
Cheng, Samuel M. S.
Perera, Ranawaka A. P. M.
Cowling, Benjamin J.
Poon, Leo L. M.
Peiris, Malik
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-020-20247-4
- URN
-
urn:nbn:de:101:1-2021020120123288999521
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lau, Eric H. Y.
- Tsang, Owen T. Y.
- Hui, David S. C.
- Kwan, Mike Y. W.
- Chan, Wai-hung
- Chiu, Susan S.
- Ko, Ronald L. W.
- Chan, Kin H.
- Cheng, Samuel M. S.
- Perera, Ranawaka A. P. M.
- Cowling, Benjamin J.
- Poon, Leo L. M.
- Peiris, Malik
- SpringerLink (Online service)
Ähnliche Objekte (12)
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy
Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys
Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy
Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys
Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Neutralizing antibody responses 300 days after SARS‐CoV‐2 infection and induction of high antibody titers after vaccination
Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy
Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys
Differential persistence of neutralizing antibody against SARS-CoV-2 in post immunized Bangladeshi population
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses